Timothy P. LaBranche

1.6k total citations · 1 hit paper
19 papers, 991 citations indexed

About

Timothy P. LaBranche is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Timothy P. LaBranche has authored 19 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Timothy P. LaBranche's work include Chemokine receptors and signaling (3 papers), Immunotherapy and Immune Responses (3 papers) and T-cell and B-cell Immunology (3 papers). Timothy P. LaBranche is often cited by papers focused on Chemokine receptors and signaling (3 papers), Immunotherapy and Immune Responses (3 papers) and T-cell and B-cell Immunology (3 papers). Timothy P. LaBranche collaborates with scholars based in United States, Chile and Germany. Timothy P. LaBranche's co-authors include Debra M. Meyer, Michael I. Jesson, Chad Storer, John C. Minnerly, John J. O’Shea, Kamran Ghoreschi, Scott Steward-Tharp, Martin E. Dowty, Massimo Gadina and Zaher A. Radi and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and American Journal Of Pathology.

In The Last Decade

Timothy P. LaBranche

19 papers receiving 965 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)

2011 514 citations Kamran Ghoreschi, Michael I. Jesson et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timothy P. LaBranche United States	13	340	280	238	237	115	19	991
Robert Ortmann United States	15	355 1.0×	318 1.1×	196 0.8×	191 0.8×	51 0.4×	21	873
Ho‐Youn Kim South Korea	13	632 1.9×	271 1.0×	207 0.9×	220 0.9×	53 0.5×	18	1.0k
Sarah Krausz Netherlands	15	433 1.3×	170 0.6×	197 0.8×	578 2.4×	86 0.7×	26	1.2k
D. Butler United Kingdom	12	400 1.2×	371 1.3×	281 1.2×	228 1.0×	73 0.6×	19	1.0k
M Feldmann United Kingdom	11	512 1.5×	653 2.3×	288 1.2×	216 0.9×	73 0.6×	18	1.3k
Brian Crain United States	17	587 1.7×	135 0.5×	169 0.7×	259 1.1×	75 0.7×	31	976
Takaichi Shimozato Japan	17	520 1.5×	199 0.7×	160 0.7×	439 1.9×	45 0.4×	30	1.2k
Satoshi Tanaka Japan	6	728 2.1×	192 0.7×	133 0.6×	229 1.0×	84 0.7×	7	1.1k
Guo‐Min Deng China	19	923 2.7×	490 1.8×	158 0.7×	304 1.3×	46 0.4×	41	1.4k
Kouji Matsushima Japan	16	447 1.3×	104 0.4×	282 1.2×	333 1.4×	78 0.7×	21	1.1k

Countries citing papers authored by Timothy P. LaBranche

Since Specialization

Citations

This map shows the geographic impact of Timothy P. LaBranche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy P. LaBranche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy P. LaBranche more than expected).

Fields of papers citing papers by Timothy P. LaBranche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy P. LaBranche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy P. LaBranche. The network helps show where Timothy P. LaBranche may publish in the future.

Co-authorship network of co-authors of Timothy P. LaBranche

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy P. LaBranche. A scholar is included among the top collaborators of Timothy P. LaBranche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy P. LaBranche. Timothy P. LaBranche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

LaBranche, Timothy P., Anna K. Kopec, Srinivasa R. Mantena, et al.. (2020). Zucker Lean Rats With Hepatic Steatosis Recapitulate Asymptomatic Metabolic Syndrome and Exhibit Greater Sensitivity to Drug-Induced Liver Injury Compared With Standard Nonclinical Sprague-Dawley Rat Model. Toxicologic Pathology. 48(8). 994–1007. 2 indexed citations

Radi, Zaher A., et al.. (2018). Renal and Hematologic Comparative Effects of Dissociated Agonist of the Glucocorticoid Receptor and Prednisone in Dogs With and Without Food Restriction. International Journal of Toxicology. 37(3). 223–233. 5 indexed citations

Rahal, Rami, Michelle Maynard, Wei Hu, et al.. (2018). Abstract B151: BLU-667 is a potent and highly selective RET inhibitor being developed for RET-driven cancers. Molecular Cancer Therapeutics. 17(1_Supplement). B151–B151. 5 indexed citations

Nabhan, Joseph F., Kristy Wood, Varada P. Rao, et al.. (2016). Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich’s ataxia. Scientific Reports. 6(1). 20019–20019. 117 indexed citations

LaBranche, Timothy P., Alison M. Bendele, Kathryn E. Gropp, et al.. (2016). Nerve growth factor inhibition with tanezumab influences weight-bearing and subsequent cartilage damage in the rat medial meniscal tear model. Annals of the Rheumatic Diseases. 76(1). 295–302. 44 indexed citations

Brodfuehrer, Joanne, Andrew L. Rankin, Jason Edmonds, et al.. (2013). Quantitative Analysis of Target Coverage and Germinal Center Response by a CXCL13 Neutralizing Antibody in a T-Dependent Mouse Immunization Model. Pharmaceutical Research. 31(3). 635–648. 17 indexed citations

Oglesbee, Michael & Timothy P. LaBranche. (2013). Inside-Out. Veterinary Pathology. 50(5). 921–924. 1 indexed citations

Carrier, Yijun, Matthew J. Whitters, Joy Miyashiro, et al.. (2012). Enhanced GITR/GITRL interactions augment IL‐27 expression and induce IL‐10‐producing Tr‐1 like cells. European Journal of Immunology. 42(6). 1393–1404. 34 indexed citations

Wang, Baomei, Bernd H. Zinselmeyer, Herbert A. Runnels, et al.. (2012). In vivo imaging implicates CCR2+ monocytes as regulators of neutrophil recruitment during arthritis. Cellular Immunology. 278(1-2). 103–112. 27 indexed citations

10.

Ghoreschi, Kamran, Michael I. Jesson, Li Xiong, et al.. (2011). Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550). The Journal of Immunology. 186(7). 4234–4243. 514 indexed citations breakdown →

11.

LaBranche, Timothy P., Debra M. Meyer, Chad Storer, et al.. (2010). Characterization of the KRN Cell Transfer Model of Rheumatoid Arthritis (KRN-CTM), a Chronic Yet Synchronized Version of the K/BxN Mouse. American Journal Of Pathology. 177(3). 1388–1396. 21 indexed citations

12.

Racz, Jennifer, et al.. (2010). Th17 cells can provide B cell help in autoantibody induced arthritis. Journal of Autoimmunity. 36(1). 65–75. 55 indexed citations

13.

LaBranche, Timothy P., Marion Ehrich, & P. Eyre. (2010). Characterization of bovine neutrophil β₂‐adrenergic receptor function. Journal of Veterinary Pharmacology and Therapeutics. 33(4). 323–331. 6 indexed citations

14.

Peterson, Jeffrey D., Timothy P. LaBranche, Kristine Vasquez, et al.. (2010). Optical tomographic imaging discriminates between disease-modifying anti-rheumatic drug (DMARD) and non-DMARD efficacy in collagen antibody-induced arthritis. Arthritis Research & Therapy. 12(3). R105–R105. 48 indexed citations

15.

Burgos, Rafael A., et al.. (2005). 14-Deoxyandrographolide as a Platelet Activating Factor Antagonist in Bovine Neutrophils. Planta Medica. 71(7). 604–608. 13 indexed citations

16.

Hidalgo, María A., P. Eyre, Timothy P. LaBranche, et al.. (2004). Platelet‐activating factor increases pH_(i)in bovine neutrophils through the PI3K–ERK1/2 pathway. British Journal of Pharmacology. 141(2). 311–321. 28 indexed citations

17.

Burgos, Rafael A., et al.. (2003). Effect of 14‐deoxyandrographolide on calcium‐mediated rat uterine smooth muscle contractility. Phytotherapy Research. 17(9). 1011–1015. 13 indexed citations

18.

LaBranche, Timothy P., et al.. (2001). Evaluation of Rat Neutrophil β-adrenergic Receptors by Microphysiometry. Veterinary Research Communications. 25(2). 149–152. 1 indexed citations

19.

Zajac, Anne M., et al.. (1998). Efficacy of fenbendazole in the treatment of experimental Giardia infection in dogs. American Journal of Veterinary Research. 59(1). 61–63. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact